Who are Aspire Biopharma Holdings, Inc.'s main suppliers?

Aspire Biopharma Holdings, Inc. (ASBPW) key suppliers include: ORANY, ORANY. View the full supplier network at chainsifter.com/chain/ASBPW.

Who are Aspire Biopharma Holdings, Inc.'s major customers?

Aspire Biopharma Holdings, Inc. (ASBPW) key customers include: ORANY, ORANY. View the full customer network at chainsifter.com/chain/ASBPW.

What sector is Aspire Biopharma Holdings, Inc. in?

Aspire Biopharma Holdings, Inc. (ASBPW) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Aspire Biopharma Holdings, Inc. (ASBPW) Suppliers & Customers

2Suppliers

2Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Aspire Biopharma Holdings, Inc. (ASBPW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

6Total relationships

1Distinct source URLs

2High confidence

0.780Average confidence

2026-09-27Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Aspire Biopharma Holdings, Inc. Suppliers

Ticker	Name	Confidence	Evidence
ORANY	ORANY	72%	uct (sometimes referred to informally herein as “Instaprin” for ease of reference) for our clinical trials required to obtain FDA approval to market the product and complete clinical trials. While we…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from ASBPW graph: uct (sometimes referred to informally herein as “Instaprin” for ease of reference) for our clinical trials required…

Aspire Biopharma Holdings, Inc. Customers

Ticker	Name	Confidence	Evidence
ORANY	ORANY	72%	uct (sometimes referred to informally herein as “Instaprin” for ease of reference) for our clinical trials required to obtain FDA approval to market the product and complete clinical trials. While we…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from ASBPW graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from ASBPW graph: Reciprocal relationship from OR…

Aspire Biopharma Holdings, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ASBPW-DEBT-7873	Warrants outstanding: 44000000	90%	xbrl warrant detail from xbrl 2024-12-31.
ASBPW-DEBT-7874	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-09-30.

Aspire Biopharma Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Aspire Biopharma Holdings, Inc..

Aspire Biopharma Holdings, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Aspire Biopharma Holdings, Inc..

Aspire Biopharma Holdings, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ORANY	ORANGE	100.00	1	['customer', 'supplier']
BLTE	Belite Bio, Inc	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
BFRIW	Biofrontera Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
D	Dominion Energy, Inc.	50.00	2
EPDU	ENTERPRISE PRODUCTS PARTNERS L.P.	50.00	2
CINGW	Cingulate Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
BFRGW	BullFrog AI Holdings, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
EQR	Equity Residential	50.00	2
CNOB	ConnectOne Bancorp, Inc.	50.00	2
BCDRF	Banco Santander, S.A.	50.00	2

Aspire Biopharma Holdings, Inc. Supply Chain